Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY)

The REMEDY center will ensure research that improves patient care in the field of rheumatology and musculoskeletal diseases, with a major impact on individuals and society. The purpose of REMEDY is to develop excellent treatments and treatment strategies in rheumatology and musculoskeletal diseases through a broad approach to the research field. Our ambition is to conduct clinical studies with the potential to change clinical practice.

The center is established with Diakonhjemmet Hospital as host institution together with Oslo University Hospital, the University of Oslo, the Norwegian Rheumatism Association and MAGIC as affiliated partners.

Our research

  • Optimized medical interventions
  • Conduct high quality clinical trials to investigate the efficacy of drugs, surgical procedures, injections and non-pharmacological interventions, as well as personalised treatment strategies

Read more
  • Phenotyping for personalized medicine
  • Identify biomarkers and genetic/epigenetic markers of treatment efficacy and disease severity, and characterise and stratify early disease

Read more
  • Pain mechanisms and management
  • Better understand underlying pain mechanisms to optimise treatment

Read more
  • Managing of comorbidities
  • Develop and evaluate strategies to detect, treat and prevent comorbidities

Read more
  • Innovative approaches to remote care
  • Develop and investigate the usability, efficacy and cost-effectiveness of personalised remote care

Read more
  • Deciphering long-term outcomes
  • Investigate long-term effects, work participation and health economic consequences of different treatment strategies through linkage to national registries

Read more
  • Empowering the individual
  • Investigate health literacy, adherence to treatment and eHealth strategies to empower patients to manage their disease

Read more

National clinical consortium

In REMEDY there is also a national clinical consortium consisting of rheumatology departments and rehabilitation institutions from all over Norway. The purpose of the consortium is to enable patients from all over Norway to participate in multicenter studies that originate from REMEDY and to support participants in the consortium to initiate their own studies.

Read more

User involvement in research

User participation in research will be central to all work packages. REMEDY has its own patient council and user representatives from this patient council will be part of the project group in the various projects. In addition, we will work closely with the Norwegian Rheumatism Association, which is also a partner in the center.

Read more

News from the REMEDY Center

Green Congress 2023
June 16, 2023

On June 16, the Green Congress was held with a focus on the environment and updates from the EULAR congress.

Read more >
Article on user participation in research
Jun 12, 2023

Editorial in Dagens Medisin that highlights that user participation can lead to better research.

Read more >
Nor-vaC study featured in national report
May 26, 2023

The Nor-vaC study is one of the projects featured in the National Report from the Specialist Health Service 2022 - Research and innovation for the benefit of patients.

Read more >


All rights reserved © REMEDY; Illustration/portrait images © Nicolas Tourrenc/Diakonhjemmet Hospital